(Q41344925)

29 September 2017

1 reference

title

Implementation of multiple outpatient formularies: undesirable effects (English)

1 reference

29 September 2017

Stein CM

1

1 reference

29 September 2017

Wood AJ

series ordinal

2

1 reference

29 September 2017

Pincus T

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Clinical Pharmacology & Therapeutics

29 September 2017

published in

1 reference

29 September 2017

volume

61

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

1-7

1 reference

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Postmarketing surveillance: curriculum for the clinical pharmacologist. Part I: Postmarketing surveillance within the continuum of the drug approval process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Promoting cost effective prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Insights into public assistance medical care expenditures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Expanding Medicaid drug formulary coverage. Effects on utilization of related services.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Experience of state drug benefit programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Therapeutic-class wars--drug promotion in a competitive marketplace

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

End of the New Zealand asthma mortality epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Scientific versus commercial sources of influence on the prescribing behavior of physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Physicians and the pharmaceutical industry. American College of Physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Understanding Financial Conflicts of Interest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Institutional conflict of interest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

The pharmacology and use of H1-receptor-antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Reduction of Incorrect Antibiotic Dosing Through a Structured Educational Order Form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

The formulary: an educational tool for clinical pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Changing physicians' practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Computer-based drug-utilization review--risk, benefit, or boondoggle?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Centers for education and research in therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

Cost effects of restricting cost-effective therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Hospital drug formularies and use of hospital services

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990175-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(97)90175-2

1 reference

29 September 2017

1 reference